Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2589)
All Articles published online
|
Jun 15, 2003 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu LH, Deng CS, Zhu YQ, Liu SQ, Liu DZ. Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. World J Gastroenterol 2003; 9(6): 1241-1245 [PMID: 12800232 DOI: 10.3748/wjg.v9.i6.1241] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1241.htm |
| Number | Citing Articles |
| 1 |
Danko Martincic, Kenneth R. Hande. . Cancer Chemotherapy and Biological Response Modifiers Annual 2005; 22: 101 doi: 10.1016/S0921-4410(04)22005-1
|
| 2 |
Leeona Galligan, Daniel B. Longley, Miranda McEwan, Timothy R. Wilson, Kirsty McLaughlin, Patrick G. Johnston. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Molecular Cancer Therapeutics 2005; 4(12): 2026 doi: 10.1158/1535-7163.MCT-05-0262
|
| 3 |
Fatemeh Siami, Homayon Ahmadpanahi, Amir Heidarinasab, Elham Moniri, Azim Akbarzadeh. Improvement of Doxorubicin Efficacy by Conjugating to pH‐Sensitive Copolymer‐Coated Magnetic Nanoparticles. Advances in Polymer Technology 2018; 37(1): 202 doi: 10.1002/adv.21657
|
| 4 |
Zhi-feng Zhu, Li-juan Chen, Rong Lu, Jing Jia, Yu Liang, Qiong Xu, Chun-lei Zhou, Li Wang, Song Wang, Zhi Yao. Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-342
|
| 5 |
Feyzi Sinan Tokalı, Halil Şenol, Tuğba Gençoğlu Katmerlikaya, Aydan Dağ, Kıvılcım Şendil. Novel thiosemicarbazone and thiazolidin‐4‐one derivatives containing vanillin core: Synthesis, characterization, and anticancer activity studies. Journal of Heterocyclic Chemistry 2023; 60(4): 645 doi: 10.1002/jhet.4619
|
| 6 |
Caroline M.M. Van Geelen, Elisabeth G.E. de Vries, Steven de Jong. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resistance Updates 2004; 7(6): 345 doi: 10.1016/j.drup.2004.11.002
|
| 7 |
Jing Zhao, Yixin Lu, Han-Ming Shen. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Letters 2012; 314(1): 8 doi: 10.1016/j.canlet.2011.09.040
|
| 8 |
Halil Şenol, Ahmet Gökhan Ağgül, Sezen Atasoy. Synthesis, Characterization, Molecular Docking and in vitro Biological Studies of Thiazolidin‐4‐one Derivatives as Anti‐Breast‐Cancer Agents. ChemistrySelect 2023; 8(20) doi: 10.1002/slct.202300481
|
| 9 |
JONG KYU WOO, JU-HEE KANG, YEONG-SU JANG, SEONGGU RO, JOONG MYUNG CHO, HWAN-MOOK KIM, SANG-JIN LEE, SEUNG HYUN OH. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL. Oncology Reports 2015; 33(4): 1947 doi: 10.3892/or.2015.3793
|
| 10 |
Mohd Muslim, Musheer Ahmad, Mohd Arish, Mohammad Jane Alam, Abdullah Alarifi, Mohd. Afzal, Nayim Sepay, Shabbir Ahmad. 5-Hydroxyisophthalic acid and neocuproine containing copper(II) complex as a promising cytotoxic agent: Structure elucidation, topology, Hirshfeld surface, DFT calculations, and molecular docking analysis. Journal of Molecular Structure 2022; 1270: 133879 doi: 10.1016/j.molstruc.2022.133879
|
| 11 |
M A I Abou El Hassan, D C J Mastenbroek, W R Gerritsen, G Giaccone, F A E Kruyt. Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. British Journal of Cancer 2004; 91(1): 171 doi: 10.1038/sj.bjc.6601910
|
| 12 |
Moloud Alinaghi, Pooneh Mokarram, Mazaher Ahmadi, Farzaneh Bozorg-ghalati. Biosynthesis of palladium, platinum, and their bimetallic nanoparticles using rosemary and ginseng herbal plants: evaluation of anticancer activity. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56275-z
|
| 13 |
Ying Gao, Junfeng Yin, Gary Rankin, Yi Chen. Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells. Molecules 2018; 23(5): 1095 doi: 10.3390/molecules23051095
|
| 14 |
Dongsun Park, Dae-Kwon Bae, Jeong Hee Jeon, Jinsoo Lee, Namgil Oh, Goeun Yang, Yun-Hui Yang, Tae Kyun Kim, Jugyeong Song, Sun Hee Lee, Byeng Sub Song, Tae Hawn Jeon, Shin Jyung Kang, Seong Soo Joo, Seung U. Kim, Yun-Bae Kim. Immunopotentiation and antitumor effects of a ginsenoside Rg3-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environmental Toxicology and Pharmacology 2011; 31(3): 397 doi: 10.1016/j.etap.2011.01.008
|
| 15 |
Alvaro Mordente, Elisabetta Meucci, Andrea Silvestrini, Giuseppe Ettore Martorana, Bruno Giardina. Advances in Mitochondrial Medicine. Advances in Experimental Medicine and Biology 2012; 942: 385 doi: 10.1007/978-94-007-2869-1_18
|
| 16 |
Tao Wang, Fei Chen, Zhe Chen, Yi-Feng Wu, Xiao-Li Xu, Shu Zheng, Xun Hu. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World Journal of Gastroenterology 2004; 10(15): 2205-2208 doi: 10.3748/wjg.v10.i15.2205
|